AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $203,000 | +105.1% | 5,895 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $99,000 | +160.5% | 5,895 | +125.9% | 0.00% | – |
| Q1 2020 | $38,000 | -56.3% | 2,609 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $87,000 | +58.2% | 2,609 | 0.0% | 0.00% | – |
| Q3 2019 | $55,000 | +1.9% | 2,609 | 0.0% | 0.00% | – |
| Q2 2019 | $54,000 | -6.9% | 2,609 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $58,000 | -6.5% | 2,609 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $62,000 | +19.2% | 2,609 | +37.2% | 0.00% | – |
| Q3 2018 | $52,000 | +2.0% | 1,901 | 0.0% | 0.00% | – |
| Q2 2018 | $51,000 | -35.4% | 1,901 | -23.7% | 0.00% | -100.0% |
| Q1 2018 | $79,000 | +36.2% | 2,490 | +63.0% | 0.00% | 0.0% |
| Q4 2017 | $58,000 | +114.8% | 1,528 | +41.6% | 0.00% | – |
| Q3 2017 | $27,000 | +22.7% | 1,079 | 0.0% | 0.00% | – |
| Q2 2017 | $22,000 | -83.1% | 1,079 | -82.0% | 0.00% | -100.0% |
| Q1 2017 | $130,000 | +490.9% | 5,979 | +454.1% | 0.00% | – |
| Q4 2016 | $22,000 | – | 1,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|